Chromatin Binding Proteins
Chromatin Binding Proteins - Related Videos
07:05
Chromatin Immunoprecipitation to Identify Target Protein Binding Sites on Genomic DNA
0 Views •
2025
In this video, we demonstrate the chromatin immunoprecipitation technique to identify protein binding sites on specific regions of the genomic DNA of oligodendrocyte precursor cells via the selective immunoprecipitation of protein-bound chromatin fragments. This method helps to study the interaction of several regulatory proteins, including transcription factors involved in gene regulation.
07:41
Sequential Salt Extractions for the Analysis of Bulk Chromatin Binding Properties of Chromatin Modifying Complexes
0 Views •
Cited by 20 •
2017
Sequential salt extraction of chromatin bound proteins is a useful tool for determining the binding properties of large protein complexes. This method can be employed to evaluate the role of individual subunits or domains in the overall affinity of a protein complex to bulk chromatin.
06:29
Chromatin Immunoprecipitation Assay: A Technique to Study Protein-DNA Interactions in Cells
0 Views •
2023
This video describes protocol for chromatin immunoprecipitation (ChIP) assay, which is a classic technique to demonstrate protein-DNA interactions.This technique is used to identify target genes in human chronic lymphocytic leukemia cells.
08:39
Chromatin Immunoprecipitation
0 Views •
2023
Histones are proteins that help organize DNA in eukaryotic nuclei by serving as “scaffolds” around which DNA can be wrapped, forming a complex called “chromatin”. These proteins can be modified through the addition of chemical groups, and these changes affect gene expression. Researchers use a technique called chromatin immunoprecipitation (ChIP) to better understand which DNA regions associate with specific histone modifications or other gene regulatory proteins. Antibodies are used to isolate...
07:51
Pull-down of Calmodulin-binding Proteins
0 Views •
Cited by 19 •
2012
Calmodulin (CaM) pull-down assay is an effective way to investigate the interaction of CaM with various proteins. This method uses CaM-sepharose beads for efficient and specific analysis of CaM-binding proteins. This provides an important tool to explore CaM signaling in cellular function.
FAQs
Chromatin binding proteins can regulate access through at least three recognition routes: specific DNA sequences, histone modifications, and broader chromatin structures. These routes help determine whether regulatory machinery can engage a genomic region. The resulting changes in accessibility can alter transcription while also influencing DNA replication and repair.
These mechanisms influence genetic access in distinct ways. A binding protein may recruit enzymes that modify or act on chromatin, reposition nucleosomes to change the exposure of DNA, or alter how tightly chromatin is compacted. Together, these actions provide several routes for controlling whether genetic information remains accessible to regulatory processes.
Binding patterns help cells establish and maintain their identities by controlling access to different parts of the genome. Because the same genome must support diverse cell states, changes in which proteins associate with DNA, histones, or chromatin structures can shift regulatory activity. Abnormal patterns may therefore contribute to disrupted gene regulation in disease.
The effects extend beyond transcription. By changing access to genetic information, these proteins can influence DNA replication and DNA repair as well as gene expression. This broad reach makes their binding activity relevant to both normal genome function and disease mechanisms, particularly when altered regulation affects several cellular processes at once.
Their binding patterns can provide information about the regulatory state of a cell. When those patterns are associated with particular disease-related changes, they may serve as biomarkers that help characterize abnormal gene regulation. This is especially relevant to cancer, developmental disorders, and other conditions in which epigenetic control becomes disrupted.
These proteins and their associated regulatory complexes influence how genetic information becomes accessible, making them potential points for therapeutic intervention. Drugs designed to modify epigenetic states may alter the regulatory conditions established by these systems. Such strategies are being considered in the context of abnormal gene regulation, including changes linked to cancer and developmental disorders.